HealthcareServices

Personal Genome Services Market Future Outlook 2026: Key Drivers and Growth Potential

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the personal genome services market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Personal Genome Services Market in 2030?

The personal genome services market has experienced substantial expansion in recent years. This market is projected to increase from $6.84 billion in 2025 to $7.85 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.7%. Historically, the growth can be attributed to falling sequencing costs, a rise in ancestry testing demand, growth in consumer genetics awareness, the expansion of genomics startups, and improved sequencing accuracy.

The personal genome services market is projected to experience substantial growth in the coming years. This market is expected to expand to $13.69 billion by 2030, achieving a compound annual growth rate (CAGR) of 14.9%. The anticipated growth over this period can be attributed to factors such as increased adoption of preventive genomics, broader usage of pharmacogenomics, rising demand for personalized wellness, more widespread insurance-supported testing, and enhanced integration with digital health platforms. Significant trends for the forecast period include direct-to-consumer genome testing, integrated health risk genomic reports, bundled pharmacogenomic services, preventive genome screening packages, and digital genetic counseling platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33258&type=smp

What Drivers Are Influencing Production Trends In The Personal Genome Services Market?

The growing emphasis on personalized medicine is projected to stimulate the expansion of the personal genome services market in the future. This medical approach involves customizing treatment and prevention plans according to an individual’s unique genetic, biological, and lifestyle attributes. Its adoption is rising, driven by progress in genomics and molecular diagnostics, enabling treatments to be specifically designed for an individual’s genetic profile, leading to improved results. Personal genome services facilitate personalized medicine through the analysis of an individual’s genetic composition, which helps in foreseeing disease risk, guiding medication choices, and customizing prevention and treatment approaches. As an illustration, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, showed that in 2023, the FDA sanctioned 16 novel personalized treatments for rare disease patients, an increase from six in 2022. Among these newly approved personalized treatments for 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the intensified focus on personalized medicine is fueling the expansion of the personal genome services market.

Which Segments Are Gaining Traction In The Personal Genome Services Market?

The personal genome services market covered in this report is segmented –

1) By Service Type: Genetic Testing; Whole Genome Sequencing; Carrier Testing; Ancestry Testing; Other Service Types

2) By Application: Healthcare; Research; Ancestry; Other Applications

3) By End-User: Hospitals and Clinics; Research Centers; Direct-to-Consumer; Other End-Users

Subsegments:

1) By Genetic Testing: Health Risk Assessment Testing; Pharmacogenomic Testing; Nutritional Genetic Testing; Lifestyle Genetic Testing; Wellness Genetic Screening

2) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; Preventive Health Genome Sequencing; Rare Disease Genome Sequencing; Population Based Genome Sequencing

3) By Carrier Testing: Inherited Disease Carrier Screening; Preconception Carrier Testing; Prenatal Carrier Testing; Reproductive Health Carrier Screening; Family Planning Carrier Testing

4) By Ancestry Testing: Ethnicity Estimation Testing; Genealogical Lineage Testing; Migration Pattern Analysis; Regional Ancestry Breakdown; Family Relationship Discovery

5) By Other Service Types: Newborn Genetic Screening; Predictive Genetic Testing; Sports Performance Genetic Analysis; Personalized Health Reporting; Custom Genetic Consulting Services

Which Trends Are Shaping Activity Within The Personal Genome Services Market?

Leading companies in the personal genome services market are concentrating on developing sophisticated solutions, such as genome-wide risk stratification, to offer personalized health insights, forecast disease susceptibility, and guide preventive and lifestyle interventions. Genome-wide risk stratification involves analyzing an individual’s entire genome to identify genetic variations contributing to the risk of developing specific diseases or conditions, enabling customized predictions of health risks and targeted preventive strategies. For instance, in November 2025, MyOme Inc., a US-based biotechnology company, launched the first integrated polygenic risk score (iPRS) test for prostate cancer. This test combines approximately 7 million genetic markers with clinical factors to deliver personalized 10-year and lifetime risk estimates, validated in over 140,000 diverse men. Its purpose is early detection and prevention for 95% of cases without rare variants such as BRCA2, guiding PSA or MRI or biopsies for high-risk individuals (those in the top decile with 3-4x elevated odds) while reducing false positives and overtreatment. Key benefits include precise stratification, equitable performance across ancestries, and lifelong AI-updated insights derived from one whole-genome sample.

Who Are The Major Companies Operating In The Personal Genome Services Market?

Major companies operating in the personal genome services market are Thermo Fisher Scientific Inc, Illumina Inc, Helix OpCo LLC, Ancestry.com Operations Inc, Fulgent Genetics Inc, 23andMe Holding Co, Prenetics Global Limited, MyHeritage Ltd, Color Health Inc, Genomics plc, GenoPalate Inc, Living DNA Ltd, Mapmygenome India Pvt Ltd, Nebula Genomics Inc, Xcode Life Sciences Pvt Ltd, Sema4 Holdings Corp, Gene by Gene Ltd, TellmeGen SL, CRI Genetics LLC, African Ancestry Inc, and DNAFit Limited.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personal-genome-services-market-report

Which Region Is Anticipated To See The Fastest Growth In The Personal Genome Services Market?

North America was the largest region in the personal genome services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personal genome services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personal Genome Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33258&type=smp

Browse Through More Reports Similar to the Global Personal Genome Services Market 2026, By The Business Research Company

Genomics Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Consumer Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-genomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795